Top Story

Physician urges FDA not to lift restrictions on drug makers’ claims about their products

July 3, 2015

Drug regulations and a governing body to mandate them is a necessity for patients’ safety and health care providers’ peace-of-mind, according to a recently released commentary in the Annals of Internal Medicine.

“As a prescriber, I have been willing to give up my freedom to prescribe any chemical I choose to patients, and I am willing to have drug manufacturers give up some of their right to tell me whatever they may want me to hear. For all of us (including patients) to hand over some liberties to a Hobbesian Sovereign, such as the FDA, offers a different kind of freedom — knowing that the medications we use are probably, at least as a first approximation, reasonably safe and have some evidence that they work,” Jerry Avorn, MD, Harvard School of Medicine, wrote in his paper.

In the Journals

Body temperature not an accurate indicator of serious bacterial infection

July 2, 2015
The accuracy of an infant’s temperature measured at presentation at the emergency department is not a reliable indicator for severe bacterial infection, according…

Gilead files NDA for once-daily HIV treatment

July 2, 2015
Gilead Sciences is seeking FDA approval for its investigational, once-daily regimen of emtricitabine 200 mg and tenofovir alafenamide 25 mg, plus Janssen…

Health officials warn of possible HIV, HBV, HCV exposure from dental procedures

July 2, 2015
New South Wales health officials have warned that more than 12,000 patients may have been exposed to HIV, hepatitis B or hepatitis C viruses as a result of poor…

California could spend nearly $5 billion on HCV drugs over next year

July 2, 2015
In a new report, California is projected to spend $4.77 billion on new treatments for hepatitis C virus infection over the next 12 months to aid people with the…
More News Headlines »
CME
Infectious Disease Case Consults

The Patient at Risk for HIV Infection

No commercial support for this activity.

This CME activity will focus on the utilization of PrEP in patients at risk for developing HIV infection supplemented…
More »
At Issue Video
VIDEO: James A. Hoxie, MD, discusses intense energy of emerging HIV cure research

VIDEO: James A. Hoxie, MD, discusses intense energy of emerging HIV cure research

July 1, 2015
The “intense” energy felt by scientists working on HIV research comes from the relatively recent idea that…
More »
CME
Infectious Disease Case Consults

The Patient with Hepatitis C

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with hepatitis C.
More »
morganatic-roan